Biotech Values

[biomaven0]

harm done to pfs in Met- patients in MetMab plus Tarceva

That space is particularly confusing, with the possibility of agonism instead of antagonism and the inverse results seen by Aveo's rival compound.

I sometimes think we would learn a lot more with an intensive study of a few patients than we do with a traditional trial.

Peter